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Abstract
Most inducible expression vectors for the budding yeast Saccharomyces cerevisiae are based on galactose-inducible
promoters. Yeast has been increasingly used to study vertebrate steroid receptors because of its powerful genetics. In principle,
both regulatory systems are compatible and can be combined in the same strain. However, we found that commercial galactose
can be contaminated by bioactive estrogen and progesterone at concentrations that are sufficient to fully activate their cognate
receptors. Since steroids can elicit biological responses in pathogenic fungi and possibly other microorganisms, such
contaminants in a commonly used fermentable carbon source may need to be screened for. z 1998 Federation of European
Microbiological Societies. Published by Elsevier Science B.V.
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1. Introduction
Galactose is commonly used as a fermentable car-
bon source for a large variety of microorganisms
including the budding yeast Saccharomyces cerevi-
siae. Since S. cerevisiae prefers glucose over galactose
it represses genes needed for galactose utilization in
the presence of glucose [1]. The galactose-inducible
GAL1-GAL10 promoters have been exploited for the
development of the most widely used regulated ex-
pression systems in this species [2]. S. cerevisiae has
become a genetic test tube to study vertebrate steroid
receptors (reviewed in [3]) such as the estrogen [4]
and progesterone receptors [5]. Since their cognate
steroid ligands are generally gratuitous signals in
budding and ¢ssion yeasts, these hormone-dependent
transcription factors have provided new tools for
regulated expression [6^8]. Here we report on an
unexpected di⁄culty in combining the two inducible
expression systems.
2. Materials and methods
2.1. Plasmids
The human estrogen receptor (hER) and the
chicken progesterone receptor (cPR) were expressed
from plasmids pG/ER(G) and pG/cPR, respectively.
These are all based on vector pG-1 [6] which ensures
high level constitutive expression independent of car-
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bon source. pG/ER(G) is essentially identical to the
previously described plasmid pG/hER [9] except that
it encodes wild-type hER (glycine at position 400).
pG/cPR was constructed by inserting a BamHI-BglII
fragment from plasmid cPR1 [10], containing the
cPR coding sequences and about 80 bp of 3P £ank-
ing sequences from the rabbit L-globin gene, into
the BamHI site of pG-1. The reporter plasmid with
progesterone/glucocorticoid response elements,
pUCjSS-26X, is a pUC derivative of plasmid
pSX26.1 [11]. pUCvSS-ERE is a reporter plasmid
containing estrogen response element [12].
2.2. L-Galactosidase assays
The strain RMY326 (MATa his3 leu2-3,112 trp1-1
ura3-52) (a gift from R. Movva, Sandoz, Basel) was
transformed with plasmids encoding the mammalian
steroid receptors along with their corresponding L-
galactosidase reporter genes by the lithium acetate/
polyethyleneglycol method. pUCvSS-26X was used
to monitor the activation of cPR. pUCvSS-ERE
served to assess the activation of the hER. Trans-
formants were cultured overnight at 30‡C in minimal
synthetic medium containing 2% glucose as the car-
bon source, diluted 20-fold to obtain low density
cultures and incubated for 12^18 h in the absence
or presence of inducing agents. 40% (w/v) stock sol-
utions (= 2.2 M) of galactose preparations were pre-
pared in H2O. Steroid hormones were added from
1000U stocks in ethanol. L-Galactosidase assays
were performed as described [13] and corrected for
cell density.
2.3. Extraction of steroids from galactose
1 ml of organic solvent (ethyl acetate, dichloro-
methane, carbon tetrachloride or ether) was added
to 0.5 ml of the galactose stock solution in a micro-
fuge tube. The mixture was thoroughly vortexed.
After centrifugation the organic phase was taken
and dried in a speed vac and resolubilized in 40 Wl
ethanol and further diluted in growth medium.
2.4. Steroid measurements
Estrogen and progesterone concentrations were
determined by the Laboratoire d’Hormonologie at
the Hospital of the University of Geneva on a VI-
DAS system with the commercially available enzyme
linked £uorescent assay kits ‘VIDAS Estradiol II’
and ‘VIDAS Progesterone’ (BioMeŁrieux SA).
3. Results and discussion
3.1. A galactose preparation activates steroid
receptors
Vertebrate steroid receptors expressed in the bud-
ding yeast S. cerevisiae are inactive unless they are
induced by the addition of cognate steroids to the
growth medium. Thus, two di¡erent proteins can be
expressed independently in a regulated fashion in the
same strain using the galactose and the steroid
regulatory systems (see for example [12]). To assay
steroid receptors in yeast, we introduced expres-
sion vectors for cPR and hER together with a
L-galactosidase reporter gene into the haploid strain
RMY326 (Fig. 1A). We monitored activation of
the receptors as a function of hormone concentration
by measuring L-galactosidase activities. In the course
of such experiments with a particular galactose prep-
aration as the carbon source, we noticed that cPR
and hER are fully activated even in the absence of
any added steroid hormone (data not shown and
Table 1). In similar experiments, we found that this
galactose preparation has the same e¡ects in another
yeast strain and also induces the human progester-
one receptor but not the glucocorticoid receptor
(data not shown). Intrigued by this ¢nding, we
undertook an analysis of the active principle in our
stock of galactose.
Di¡erent batches of the same galactose lot gave
the same result whereas galactose of higher purity
from the same supplier and galactose of similar pu-
rity from several other suppliers were negative (see
Table 1). This indicated that the inducing agent(s) is
not galactose itself but rather a contaminant(s). In-
deed, the activation of hER and cPR by small
amounts of galactose can also be monitored in the
presence of standard amounts (2%) of glucose as the
carbon source (Fig. 1B). Under these conditions the
physiological galactose response including galactose
utilization is completely repressed [1]. The biological
activity of the active galactose preparation was ti-
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trated in the presence of 2% glucose and was found
to yield a typical sigmoidal dose-response curve with
half maximal activation at about 5 and 1 mM gal-
actose for hER and cPR, respectively (Fig. 1C).
3.2. Characterization of the active agents
Using steroid receptor mutants and chimeric tran-
scription factors with the hormone binding domains
of cPR and hER, we were able to determine that the
inducing agent(s) is signaling through the hormone
binding domain. Thus, it was conceivable that this
galactose contains agonistic ligands for both recep-
tors. As a ¢rst step towards the characterization of
these putative ligands, we determined conditions for
separating the active entity from the galactose. In
line with the notion that these agents could be ster-
oids, we found that they can be extracted with sev-
eral organic solvents including ethyl acetate, di-
chloromethane, carbon tetrachloride and ether.
Like steroids, the extracted chemicals can be dried
and solubilized again in ethanol (Table 1). The ex-
traction with carbon tetrachloride is quantitative as
the remaining aqueous phase containing the galac-
tose loses all of its activity (data not shown). To
identify and quantitate the compounds, representa-
tive samples were subjected to an enzyme linked £u-
orescent assay with speci¢c monoclonal and polyclo-
nal antibodies to progesterone and to the estrogen
17L-estradiol, respectively. This analysis revealed the
presence of 17L-estradiol and progesterone in the
active galactose preparation as well as in the ethyl
acetate extracted fraction (Table 2). Considering the
galactose concentrations required for half maximal
activation (see above) these would correspond to
0.4 nM 17L-estradiol and 11 pM progesterone. For
hER this is compatible with the 17L-estradiol con-
centration required for half maximal activation [4]
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Fig. 1. Induction of steroid receptors in yeast by a commercially
available galactose. A: Diagrams of the DNA constructs intro-
duced into yeast for measuring steroid receptor activation. The
steroid receptors are constitutively expressed from the glyceralde-
hyde-3-phosphate dehydrogenase promoter (GPD). The respective
reporter genes consist of the corresponding hormone response el-
ements (HRE) upstream of a minimal promoter driving the ex-
pression of L-galactosidase. B: Galactose (Fluka, cat. # 48263),
estradiol and progesterone were added at 10 mM, 100 nM and
1 WM, respectively, to yeast strains with vector alone or express-
ing human estrogen receptor (hER) or chicken progesterone re-
ceptor (cPR). C: Dose-response curves (average of three inde-
pendent experiments) with increasing concentrations of the same
galactose preparation.
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and suggests that 17L-estradiol accounts for most if
not all of the estrogenic activity in galactose. The
polyclonal anti-17L-estradiol antiserum also weakly
crossreacts with estrone, but a signi¢cant contribu-
tion of this inactive estradiol precursor seems un-
likely. The e⁄ciency with which S. cerevisiae is
able to convert estrone to estradiol [16] would hardly
be su⁄cient. For cPR the measured concentrations
of progesterone itself cannot fully account for the
activity since half maximal activation is expected at
about 100 pM [5]. It is very likely that the value for
the progesterone concentration in 0.6 M galactose,
as determined by radioimmunoassay, is an underes-
timate. Moreover, it is possible that a variety of oth-
er steroids contributed to the cPR-inducing activity.
3.3. Implications of the steroid contamination of
galactose
We have found that a commercially available gal-
actose preparation contains estrogen and progester-
one activity. Although we have focused on these two
steroids, others may also be present. Our failure to
detect glucocorticoid activity may have been due to
the relative insensitivity of mammalian glucocorti-
coid receptor expressed in yeast [7,12,14]. The ‘mi-
crobiology grade’ galactose preparations from di¡er-
ent suppliers are devoid of steroid activity, and
initially we had no reason to suspect that ‘biotech-
nology grade’ galactose would be any di¡erent. In-
terestingly, the galactose with bioactive steroids is
manufactured from bovine whey (Fluka, personal
communication). Milk, from which whey and thus
galactose are puri¢ed, is known to contain consider-
able concentrations of various steroids (for review,
see [15]). Indeed, using our yeast bioassay system for
steroids, we found that commercially available whole
milk can induce cPR (Table 1).
Bacto-peptone, a supplement commonly used in
rich medium, has previously been reported to con-
tain signi¢cant amounts of the estradiol precursor
estrone, which can be converted to estradiol at pM
concentrations by S. cerevisiae [16]. Thus, medium
supplements can be an unexpected source of bioac-
tive steroids. These ¢ndings are not only of impor-
tance for those wishing to combine steroid and ga-
lactose inductions in yeast. The characterization of
the growth and di¡erentiation properties of patho-
genic microorganisms in basic research or in clinical
testing can be adversely a¡ected by contaminating
steroids. For example, the pathogenic yeasts Candida
albicans and Paracoccidioides brasiliensis contain es-
trogen-binding proteins and respond di¡erentially to
male and female sex steroids [17^20]. Estrogens have
a dramatic e¡ect on Paracoccidioides brasiliensis by
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Table 1
Steroid receptor-inducing activity of galactose preparations
Added reagenta Steroid receptor
activationb
hER cPR
Glucose 3 3
Galactose (Fluka, cat. # 48263)c + +
Galactose (Fluka, cat. # 48259) 3 3
Galactose (Fluka, cat. # 48260) 3 3
Galactose (Merck, cat. # 104058 3 3
Galactose (Difco) 3 3
Extractable activityd
Carbon tetrachloride 100% 100%
Ether 30% n.d.f
Ethyl acetate 100% n.d.
Dichloromethane 50% n.d.
Whole milke 3 +
aGlucose or galactose were added at 2% (111 mM).
b3 and +, no activation and full activation.
c‘Biotechnology grade’, lot # 353548/1.
dAmounts added correspond to those present in 10 mM galactose.
ePasteurized whole milk was diluted 3-fold into minimal medium.
fn.d., not determined.
Table 2
Quantitation of steroids in galactose by radioimmunoassay
Galactose 10 mM1 Steroids extracted from 10 mM galactoseb Steroids extracted from 600 mM galactoseb
17L-Estradiol 220 pg ml31 (= 0.8 nM) 193 pg ml31 (= 0.7 nM) n.d.c
Progesterone undetectable undetectable 2.1 ng ml31 (= 6.7 nM)
aGalactose from Fluka, cat. # 48263 (lot # 353548/1).
bExtracted with ethyl acetate and diluted back to original concentration.
cn.d., not determined.
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inhibiting the mycelium to yeast transformation [21].
In analyzing novel pathogenic microorganisms it is
particularly important to be able to avoid bioactive
contaminants in medium supplements such as the
carbon source galactose.
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